Your Health Plan:
Your Health Plan:
Not SelectedADALIMUMAB (adalimumab) is a biosimilar prescription drug for treatment of Rheumatoid Arthritis, Juvenile arthritis, Juvenile polyarthritis, Arthritis, Psoriatic, Ankylosing spondylitis, Crohn Disease, Ulcerative Colitis and Psoriasis. ADALIMUMAB is a tumor necrosis factor blocker. It is available in the form of subcutaneous injection.
See full Prescribing Information for important safety information and clinical studies.
Cash price for 30-day supply is $1100-1400.
No saving program is found for ADALIMUMAB.
Other alternatives to ADALIMUMAB may include:
